Martin Babler, President, CEO at Principia Biopharma Inc. (PRNB), sold 52,160 shares at $51.80 ($2.8M) on 2019-12-17, disclosed to the SEC on 2019-12-19.
Open-market sale of $2.8M PRNB by President, CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.80 | 5,840 | $303K | 10.9% |
| 2 | $52.86 | 11,485 | $607K | 21.9% |
| 3 | $52.86 | 11,485 | $607K | 21.9% |
| 4 | $53.94 | 6,661 | $359K | 12.9% |
| 5 | $53.94 | 6,661 | $359K | 12.9% |
| 6 | $54.35 | 1,014 |
| $55K |
| 2.0% |
| 7 | $54.36 | 1,014 | $55K | 2.0% |
| 8 | $52.77 | 1,000 | $53K | 1.9% |
| 9 | $53.69 | 2,205 | $118K | 4.3% |
| 10 | $53.69 | 2,205 | $118K | 4.3% |
| 11 | $54.28 | 1,295 | $70K | 2.5% |
| 12 | $54.28 | 1,295 | $70K | 2.5% |
| Total | $53.21 avg | 52,160 | $2.8M | 100% |
| Filing → |
| PRNB | SELL | 2020-03-05 | $1.9M | — | Filing → |